Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)
China · Delayed Price · Currency is CNY 12.43
+0.01 (0.08%)
Aug 20, 2026, 3:04 PM CST
SHE:300705 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 499.74 | 453.7 | 443.31 | 425.05 | 345.84 | 398.41 |
Trading Asset Securities | 120.05 | 161.29 | 260.71 | 90.29 | 90.26 | 100.31 |
Cash & Short-Term Investments | 619.79 | 614.99 | 704.02 | 515.34 | 436.1 | 498.72 |
Cash Growth | -24.33% | -12.65% | 36.61% | 18.17% | -12.56% | 268.72% |
Accounts Receivable | 468.6 | 506.59 | 469.33 | 625.76 | 503.58 | 284.9 |
Other Receivables | 5.14 | 5.44 | 7.46 | 3.72 | 0.49 | 2.15 |
Receivables | 473.73 | 512.03 | 476.8 | 629.48 | 504.07 | 287.05 |
Inventory | 380.29 | 350.68 | 367.7 | 265.53 | 241.04 | 214.48 |
Other Current Assets | 71.19 | 61.6 | 53.26 | 19.61 | 25.28 | 20.03 |
Total Current Assets | 1,545 | 1,539 | 1,602 | 1,430 | 1,206 | 1,020 |
Property, Plant & Equipment | 1,609 | 1,573 | 1,355 | 1,141 | 892.29 | 606.83 |
Long-Term Investments | 250.37 | 193.42 | 122.29 | 30 | 30 | - |
Goodwill | 0.27 | 0.27 | - | - | - | - |
Other Intangible Assets | 571.11 | 561.26 | 111.58 | 88.82 | 91.66 | 77.36 |
Long-Term Deferred Tax Assets | 59.31 | 57.99 | 49.52 | 66.29 | 43.25 | 29.19 |
Long-Term Deferred Charges | 42.74 | 39.73 | 42.69 | 27.69 | 10.73 | 3.16 |
Other Long-Term Assets | 41.89 | 53.69 | 90.63 | 87.47 | 25.29 | 8.43 |
Total Assets | 4,120 | 4,019 | 3,373 | 2,871 | 2,300 | 1,745 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 117.66 | 91.15 | 150.72 | 159.29 | 143.8 | 108.88 |
Accrued Expenses | 33.27 | 85.16 | 81.17 | 80.59 | 85.84 | 47.27 |
Short-Term Debt | 20.01 | 12.01 | - | 51.85 | 71.57 | 53.77 |
Current Portion of Long-Term Debt | 46.25 | 44.48 | 8.89 | 5.95 | 13.12 | 50.54 |
Current Portion of Leases | - | 0.47 | 0.05 | 0.11 | 0.11 | - |
Current Income Taxes Payable | 40.18 | 34.51 | 3.22 | 8.92 | 0.69 | 7.73 |
Current Unearned Revenue | 61.82 | 46.69 | 30.42 | 37.27 | 72.25 | 57.41 |
Other Current Liabilities | 94.89 | 107.98 | 117.39 | 71.58 | 56.97 | 44.79 |
Total Current Liabilities | 414.09 | 422.44 | 391.86 | 415.56 | 444.34 | 370.38 |
Long-Term Debt | 625.87 | 566.2 | 293.77 | 332.48 | 231.49 | 224.28 |
Long-Term Leases | 0.6 | 0.74 | - | 0.05 | 0.15 | - |
Long-Term Unearned Revenue | 228.22 | 233.32 | 155.95 | 145.37 | 65.52 | 51.25 |
Long-Term Deferred Tax Liabilities | 9.74 | 9.9 | 4.82 | 4.47 | 5.59 | - |
Total Liabilities | 1,279 | 1,233 | 846.4 | 897.93 | 747.09 | 645.9 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 500.29 | 500.29 | 496.19 | 345.15 | 342.94 | 234.69 |
Additional Paid-In Capital | 458.47 | 481.5 | 563.55 | - | 484.87 | 278.97 |
Retained Earnings | 1,789 | 1,733 | 1,414 | 1,012 | 724.82 | 516.37 |
Treasury Stock | -100.05 | -100.05 | - | - | - | - |
Comprehensive Income & Other | 45.16 | 44.37 | 53.35 | 615.98 | - | 69.31 |
Total Common Equity | 2,693 | 2,659 | 2,527 | 1,973 | 1,553 | 1,099 |
Minority Interest | 147.91 | 127.39 | - | - | - | - |
Shareholders' Equity | 2,841 | 2,786 | 2,527 | 1,973 | 1,553 | 1,099 |
Total Liabilities & Equity | 4,120 | 4,019 | 3,373 | 2,871 | 2,300 | 1,745 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 692.74 | 623.9 | 302.71 | 390.44 | 316.44 | 328.58 |
Net Cash (Debt) | -72.95 | -8.91 | 401.31 | 124.9 | 119.66 | 170.14 |
Net Cash Growth | - | - | 221.30% | 4.38% | -29.67% | 263.28% |
Net Cash Per Share | -0.15 | -0.02 | 0.81 | 0.25 | 0.26 | 0.37 |
Filing Date Shares Outstanding | 494.11 | 494.11 | 496.19 | 483.2 | 480.11 | 459.99 |
Total Common Shares Outstanding | 494.11 | 494.11 | 496.19 | 483.2 | 480.11 | 459.99 |
Working Capital | 1,131 | 1,117 | 1,210 | 1,014 | 762.15 | 649.9 |
Book Value Per Share | 5.45 | 5.38 | 5.09 | 4.08 | 3.23 | 2.39 |
Tangible Book Value | 2,122 | 2,097 | 2,415 | 1,884 | 1,461 | 1,022 |
Tangible Book Value Per Share | 4.29 | 4.24 | 4.87 | 3.90 | 3.04 | 2.22 |
Buildings | - | 1,108 | 1,003 | 909.22 | 459.58 | 458.26 |
Machinery | - | 792.09 | 650.21 | 459.5 | 359.41 | 316.06 |
Construction In Progress | - | 135.37 | 80.97 | 69.32 | 308.14 | 18.16 |